The Speke site produces the drug Capastat
, one of few available to treat multi-drug resistant tuberculosis (MDRTB).
Two Lilly antibiotics, Capastat
and Seromycin, are used to fight the super bugs, and the company is making them available to the WHO at discounted prices.
Expansion of its Capastat
drug plant will help treat multi-drug resistant tuberculosis, which kills three million people every year, mainly in under-developedcountries.
The Speke plant is currently the sole worldwide source for the drug Capastat
, which is a vital antibiotic necessary for multiple drug-resistant tuberculosis treatment.
The plant in Speke will produce Capastat
,a drug used to treat Multi-Drug Resistant Tuberculosis (MDR-TB).